Arul Chinnaiyan, MD, PhD
Professor
Email:
[email protected]
Available to mentor
Arul Chinnaiyan, MD, PhD
Professor
Manage Your Profile
Center Memberships
-
Center MemberMM-PKUHSC Joint Institute
-
Center MemberTaubman Institute
-
Center MemberAI and Digital Health Innovation
-
Center MemberGlobal REACH
-
Center MemberRogel Cancer Center
-
Center MemberCenter for Computational Medicine and Bioinformatics
Recent Publications
-
Yi Y, Li Y, Wang R, Yu X, Liu Q, Yum C, Zhang Y, Qiao Y, Szczepanski A, Wu S, Li Q, Fazli L, Shen J, Wang X, Li X, Mu P, Schaeffer EM, Hundley HA, Niu H, Chinnaiyan AM, Wang L, Shi J, Jin J, Dong X, Zhao W, Chen K, Cao Q. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleA dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR
DOI:10.1038/s41467-026-71207-3 PMID: 41882000 -
Pun M, Deogharkar A, Natarajan SK, Nuechterlein N, Tian W, Ji S, Young E, Yang F, Hawes D, Andren AC, Owen JH, Rau S, Su F, Cao X, Parolia A, Prince M, Fry J, Gardner PA, Yang R, Judkins AR, Koschmann CJ, Venteicher AS, Lyssiotis CA, Chinnaiyan AM, Venneti S. Acta Neuropathologica, 2026 Dec 1; 152 (1):Journal ArticleTargeting chordoma via an isocitrate dehydrogenase-1-dependent susceptibility to redox metabolism
DOI:10.1007/s00401-026-03048-9 PMID: 42493667 -
Wang XM, Zhang Y, Mannan R, Zhou J, Wang S, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Modern Pathology, 2026 Nov 1; 39 (11):Journal ArticleDisentangling the Cellular Composition of FLCN-Mutated Tumors in Birt-Hogg-Dubé Syndrome by Spatial Transcriptomics
DOI:10.1016/j.modpat.2026.101083 PMID: 42754233 -
Vo JN, Wu Y-M, Heider A, Cao X, Wang R, Pham T, Teo GC, Magge SN, Parmar H, Mody R, Robinson DR, Chinnaiyan AM. N Engl J Med, 2026 Oct 15; 395 (15): 1555 - 1558.Journal ArticleIntegration-Associated Paraspinal Neoplasm after AAV Gene Therapy.
DOI:10.1056/NEJMc2607927 PMID: PMC13671263 -
Lum J, Nuechterlein N, Sliger S, Eyunni S, Tamrazi B, Blüml S, Tian W, Deogharkar A, Sweha SR, Mota M, Bayliss J, Peterson E, Ji S, Wittwer M, Bhat K, Mott BT, Hamanishi ET, Merkuri F, Azambuja A, Conceicao H, Su F, Cao X, Pandey R, Ljare OB, Parolia A, Yadav VN, Wahl DR, Koschmann C, Simoes-Costa M, Pichumani K, Wang S, Chinnaiyan AM, Venneti S. 2026 Oct 8; bioRxiv,PreprintLactate epigenetically shapes tumor cell states in H3K27M diffuse midline gliomas
DOI:10.64898/2026.10.02.756321 -
Cheng C, Pakkan R, Chinnaiyan AM, Lyssiotis CA. Genes Development, 2026 Oct 1; 40 (19-20): 1578 - 1597.Journal ArticleLysosomal metabolism in pancreatic cancer and its crosstalk with host physiology
DOI:10.1101/gad.353702.126 PMID: 42562573 -
Zheng Y, Cheng C, Cao Y, Cruz G, Zhang Y, Paturu R, Mahapatra S, Hu J, Mannan R, Karabürk H, Bhattacharyya R, Yin Y, Zhao Y, Liu W, Cao X, Xue H, Li C, Wang Z, Miner SJ, Reichert ZR, Mehra R, Vaishampayan U, Sahai V, Weisman LS, Ding K, Lyssiotis CA, Wang Y, Chinnaiyan AM, Qiao Y. Cancer Cell, 2026 Sep 14; 44 (9): 1761 - 1778.e12.Journal ArticleA stress-adaptive lipid kinase axis defines metabolic vulnerabilities in neuroendocrine prostate cancer
DOI:10.1016/j.ccell.2026.07.003 PMID: 42546705 -
Shen W, Liu Y, Liu L, Liu Y, Zhang Y, Chen Y, Wang L, Zhou Z, Zhang A, Shen H, Zhou F, Huang W, Ren X, Parolia A, Xu Y, Zhou Y, Wang Z, Chinnaiyan AM, Ding K. 2026 Sep 15; bioRxiv,PreprintSingle-Atom Modification Enables Reversal of Degradation Selectivity between NSD2 and GSPT1
DOI:10.64898/2026.09.09.750440
Featured News & Stories
Health Lab
Comprehensive DNA sequencing reveals hidden drivers of cancer
Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
Health Lab
Researchers create new path to target hard-to-drug prostate cancer protein
University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.
Illuminate
The Answers in the Epigenome
Rogel Cancer Center researchers study how epigenetics regulates cancer-related genes, aiming to improve therapies, prevention strategies, and patient outcomes.
Health Lab
Researchers identify new therapeutic target for neuroendocrine tumors in the gastrointestinal tract
University of Michigan researchers have identified a new target that can suppress tumor growth. Their findings may lead to new treatment methods for gastroenteropancreatic neuroendocrine tumors.
Health Lab
Additional testing can improve kidney cancer diagnosis
Michigan Medicine findings suggest further investigation of FISH-negative tests for renal cell carcinoma could lead to more accurate diagnosis.
Health Lab
Researchers find a targeted approach to shut down prostate cancer growth
Study shows a novel compound that degrades key proteins found in prostate cancer cells blocks oncogenic androgen receptor signaling.